Most Recent
A former executive of hospital operator Healthe Care has been sentenced and fined $10,000 after pleading guilty to one charge of insider trading for acquiring a large number of the company's shares while in possession of inside information regarding plans to acquire a rival hospital operator.
Pharmaceutical ingredient producer Alkaloids of Australia has pleaded guilty to cartel conduct over the supply of a key chemical found in generic stomach cramp drugs.
The Northern Territory government has been hit with a class action alleging it discriminated against Indigenous Australians in Wadeye by failing to provide proper healthcare services.
Johnson & Johnson unit Ethicon will now be on the hook for damages to 11,000 women implanted with defective pelvic mesh devices, after the High Court declined to hear its appeal of a ruling that found it failed to adequately warn about the devices' risks.
Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.
A group of 134 workers in healthcare, education and construction have argued a judge should grant them a temporary exemption from Victoria's direction mandating essential employees be vaccinated against COVID-19 to work outside their homes.
A judge has rejected part of IVF provider Virtus Health’s bid for redactions in a recent decision from the court temporarily blocking the company from purchasing rival Adora Fertility, saying some of the confidentiality claims were “staggering” and “border on ridiculous.”
Eastern Health and the Royal Women's Hospital have become the latest hospital operators to be stung with a class action alleging they failed to pay junior doctors for unrostered work hours.
The New South Wales Civil and Administrative Tribunal has struck down another challenge to a public health order mandating COVID-19 vaccinations for healthcare workers, saying it lacked the necessary jurisdiction to review the order's merits.
The Australian Competition and Consumer Commission has won an injunction to stop Virtus from completing the purchase of rival Adora Fertility until a court has ruled on the competition regulator's challenge to the acquisition.